Global Non-Invasive Liquid Biopsy Market, 2021-2027

Global Non-Invasive Liquid Biopsy Market, 2021-2027

A liquid biopsy can be used for molecular characterization of the tumor and its non-invasive nature allows repeat sampling to monitor genetic changes over time without the need for a tissue biopsy. According to market research study published by Gen Consulting Company, the global non-invasive liquid biopsy market stood at around USD 1,467 million in 2020 and is projected to rise to a worth of USD 4,072 million by 2027 end, thereby garnering a CAGR of 15.7% during 2021-2027.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global non-invasive liquid biopsy market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments.

The non-invasive liquid biopsy market is segmented on the basis of product, technology, sample, application, and application. The non-invasive liquid biopsy market is segmented as below:

By product:

• kits and assays
• services

By technology:

• polymerase chain reaction (PCR)
• sequencing
• microarray
• others

By sample:

• faeces
• urine
• saliva
• others

By application:

• application
• oncology
• reproductive health
• metabolic disorders
• others

By region:

• Asia Pacific
• Europe
• North America
• Rest of the World (RoW)

The report explores the recent developments and profiles of key vendors in the Global Non-Invasive Liquid Biopsy Market, including Analytik Jena AG, EXACT Sciences Corporation, Exosome Diagnostics, Inc. (Bio-Techne Corporation), Lonza Group AG (Exosomics Siena S.p.A), MDxHealth BV, Merck KGaA, OraSure Technologies, Inc., PerkinElmer, Inc., QIAGEN N.V., Thermo Fisher Scientific Inc., among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2017 to 2027 considering 2020 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global non-invasive liquid biopsy market.
• To classify and forecast the global non-invasive liquid biopsy market based on product, technology, sample, application, and application.
• To identify drivers and challenges for the global non-invasive liquid biopsy market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global non-invasive liquid biopsy market.
• To identify and analyze the profile of leading players operating in the global non-invasive liquid biopsy market.

Why Choose This Report

• Gain a reliable outlook of the global non-invasive liquid biopsy market forecasts from 2021 to 2027 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.